These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 15041707

  • 1. A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin beta.
    He LZ, Ramakrishna V, Connolly JE, Wang XT, Smith PA, Jones CL, Valkova-Valchanova M, Arunakumari A, Treml JF, Goldstein J, Wallace PK, Keler T, Endres MJ.
    Clin Cancer Res; 2004 Mar 15; 10(6):1920-7. PubMed ID: 15041707
    [Abstract] [Full Text] [Related]

  • 2. Toll-like receptor agonists shape the immune responses to a mannose receptor-targeted cancer vaccine.
    He LZ, Weidlick J, Sisson C, Marsh HC, Keler T.
    Cell Mol Immunol; 2015 Nov 15; 12(6):719-28. PubMed ID: 25345808
    [Abstract] [Full Text] [Related]

  • 3. Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells.
    Ramakrishna V, Vasilakos JP, Tario JD, Berger MA, Wallace PK, Keler T.
    J Transl Med; 2007 Jan 25; 5():5. PubMed ID: 17254349
    [Abstract] [Full Text] [Related]

  • 4. Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules.
    Ramakrishna V, Treml JF, Vitale L, Connolly JE, O'Neill T, Smith PA, Jones CL, He LZ, Goldstein J, Wallace PK, Keler T, Endres MJ.
    J Immunol; 2004 Mar 01; 172(5):2845-52. PubMed ID: 14978085
    [Abstract] [Full Text] [Related]

  • 5. Fusion of hC3d3 to hCGbeta enhances responsiveness in vitro of human peripheral immunocompetent cells upon the antigen primary challenge.
    Li HP, He XJ, Tang CL, Yao XY, Li DJ.
    J Reprod Immunol; 2008 Jul 01; 78(2):115-24. PubMed ID: 18479753
    [Abstract] [Full Text] [Related]

  • 6. The distinct effects of three tandem repeats of C3d in the immune responses against tumor-associated antigen hCGbeta by DNA immunization.
    Guan QD, Wang Y, Chu YW, Wang LX, Ni J, Guo Q, Xiong SD.
    Cancer Immunol Immunother; 2007 Jun 01; 56(6):875-84. PubMed ID: 17086422
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the immunogenicity of a single chain chimeric peptide composed of hCGβ and oLHα for inhibition of the growth of hCGβ-expressing cancer cells.
    Jiang C, Jiang Y, Huang Z, Shen W, Wang J, Shen Q.
    Cancer Immunol Immunother; 2010 Dec 01; 59(12):1771-9. PubMed ID: 20809357
    [Abstract] [Full Text] [Related]

  • 8. Reduction of bladder cancer cell growth in response to hCGbeta CTP37 vaccinated mouse serum.
    Butler SA, Staite EM, Iles RK.
    Oncol Res; 2003 Dec 01; 14(2):93-100. PubMed ID: 14649543
    [Abstract] [Full Text] [Related]

  • 9. Mucosal inoculation of Lactobacillus expressing hCGbeta induces an anti-hCGbeta antibody response in mice of different strains.
    Yao XY, Yuan MM, Li DJ.
    Methods; 2006 Feb 01; 38(2):124-32. PubMed ID: 16414267
    [Abstract] [Full Text] [Related]

  • 10. Assessing vaccine potency using TCRmimic antibodies.
    Neethling FA, Ramakrishna V, Keler T, Buchli R, Woodburn T, Weidanz JA.
    Vaccine; 2008 Jun 13; 26(25):3092-102. PubMed ID: 18353510
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
    Schnurr M, Galambos P, Scholz C, Then F, Dauer M, Endres S, Eigler A.
    Cancer Res; 2001 Sep 01; 61(17):6445-50. PubMed ID: 11522639
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7.
    Nonn M, Schinz M, Zumbach K, Pawlita M, Schneider A, Dürst M, Kaufmann AM.
    J Cancer Res Clin Oncol; 2003 Sep 01; 129(9):511-20. PubMed ID: 12905010
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The fusion protein of HSP65 with tandem repeats of beta-hCG acting as a potent tumor vaccine in suppressing hepatocarcinoma.
    Xiangbing H, Yankai Z, Ming L, Yong L, Yu Z, Huiyong Z, Yingying C, Jing H, Yun X, Liang J, Rongyue C, Jingjing L.
    Int Immunopharmacol; 2010 Feb 01; 10(2):230-8. PubMed ID: 19913113
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.